Part 3/8:
Some people worry that the accelerated timeline of COVID-19 vaccine development might compromise safety. Experts reassure that, despite the rapid pace, the vaccine development process retains rigorous safety standards. Extensive research and thorough clinical studies are necessary before a vaccine can be approved for widespread use. Accelerating this process hinges on involving more participants in clinical trials, which helps gather data more quickly and facilitates faster decision-making without cutting corners on safety.